Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Clinical Neuropharmacology
|
December 9, 1998
Neurodevelopmental consequences of early exposure to phencyclidine and related drugs
S I Deutsch, J Mastropaolo, R B Rosse
Clinical Neuropharmacology
|
December 1, 1995
The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders
J Karatinos, R B Rosse, S I Deutsch
Clinical Neuropharmacology
|
May 14, 1998
Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia
S I Deutsch, R B Rosse, J Mastropaolo
Journal of Clinical Psychopharmacology
|
April 1, 1990
Thyroid hormone supplementation of fluoxetine treatment
D Crowe, J P Collins, R B Rosse
The Journal of Clinical Psychiatry
|
September 1, 1986
Baclofen treatment in a patient with tardive dystonia
R B Rosse, A Allen, W E Lux
Clinical Neuropharmacology
|
June 1, 1994
Environmental stress-induced functional modification of the central benzodiazepine binding site
S I Deutsch, R B Rosse, J Mastropaolo
Military Medicine
|
November 1, 1986
Utilization of psychiatric consultation with an elderly medically ill inpatient population in a VA hospital
R B Rosse, C P Ciolino, L Gurel
Clinical Neuropharmacology
|
October 23, 1997
Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice
S I Deutsch, R B Rosse, J Mastropaolo
Clinical Neuropharmacology
|
June 1, 1997
Pupillary changes associated with the development of stimulant-induced mania: a case report
R B Rosse, S K Johri, S I Deutsch
Psychosomatics
|
January 1, 1992
Thalamic pain syndrome complicating the evaluation of a patient with poststroke depression
J A Huntzinger, S I Deutsch, R B Rosse
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Clinical Neuropharmacology
|
December 9, 1998
Neurodevelopmental consequences of early exposure to phencyclidine and related drugs
S I Deutsch, J Mastropaolo, R B Rosse
Clinical Neuropharmacology
|
December 1, 1995
The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders
J Karatinos, R B Rosse, S I Deutsch
Clinical Neuropharmacology
|
May 14, 1998
Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia
S I Deutsch, R B Rosse, J Mastropaolo
Journal of Clinical Psychopharmacology
|
April 1, 1990
Thyroid hormone supplementation of fluoxetine treatment
D Crowe, J P Collins, R B Rosse
The Journal of Clinical Psychiatry
|
September 1, 1986
Baclofen treatment in a patient with tardive dystonia
R B Rosse, A Allen, W E Lux
Clinical Neuropharmacology
|
June 1, 1994
Environmental stress-induced functional modification of the central benzodiazepine binding site
S I Deutsch, R B Rosse, J Mastropaolo
Military Medicine
|
November 1, 1986
Utilization of psychiatric consultation with an elderly medically ill inpatient population in a VA hospital
R B Rosse, C P Ciolino, L Gurel
Clinical Neuropharmacology
|
October 23, 1997
Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice
S I Deutsch, R B Rosse, J Mastropaolo
Clinical Neuropharmacology
|
June 1, 1997
Pupillary changes associated with the development of stimulant-induced mania: a case report
R B Rosse, S K Johri, S I Deutsch
Psychosomatics
|
January 1, 1992
Thalamic pain syndrome complicating the evaluation of a patient with poststroke depression
J A Huntzinger, S I Deutsch, R B Rosse
Page
of 9